Biopharmaceutical
Pharmaceutical
Health

Esperion Therapeutics

455

$50.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.66 (+1.33%) Today
$0.00 (0.00%) As of 7:40 PM EST after-hours

Why Robinhood?

You can buy or sell ESPR and other stocks, options, ETFs, and crypto commission-free!

About ESPR

Esperion Therapeutics, Inc. operates as a clinical stage pharmaceutical company, which engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). It offers Bempedoic acid and Ezetime combination pill as therapies that have been shown to lower elevated LDL-C levels in patients with hypercholesterolemia, including patients inadequately treated with current lipid-modifying therapies. Read More The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

CEO
Tim M. Mayleben
Employees
76
Headquarters
Ann Arbor,
Founded
—
Market Cap
1.36B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
465.87K
High Today
$50.53
Low Today
$49.00
Open Price
$49.43
Volume
326.11K
52 Week High
$55.70
52 Week Low
$33.13

Collections

Biopharmaceutical
Pharmaceutical
Health
Research And Development
Therapy
Biotechnology
Medical
Technology

ESPR Earnings

-$2.52
-$0.66
$1.21
$3.07
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 27, Pre-Market

You May Also Like

ED
NTTYY
DEF
STZ.B
OILK
BFO
BDL
DMLP
FNKO
MIDU
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ESPR

Market Price$50.29
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ESPR stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up